Correlation Between Crispr Therapeutics and Caribou Biosciences

Can any of the company-specific risk be diversified away by investing in both Crispr Therapeutics and Caribou Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Crispr Therapeutics and Caribou Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Crispr Therapeutics AG and Caribou Biosciences, you can compare the effects of market volatilities on Crispr Therapeutics and Caribou Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Crispr Therapeutics with a short position of Caribou Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Crispr Therapeutics and Caribou Biosciences.

Diversification Opportunities for Crispr Therapeutics and Caribou Biosciences

0.8

Correlation Coefficient

Crispr Therapeutics  Caribou Biosciences

Very poor diversification

The 3 months correlation between Crispr and Caribou is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding Crispr Therapeutics AG and Caribou Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Caribou Biosciences and Crispr Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Crispr Therapeutics AG are associated (or correlated) with Caribou Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Caribou Biosciences has no effect on the direction of Crispr Therapeutics i.e., Crispr Therapeutics and Caribou Biosciences go up and down completely randomly.

Pair Corralation between Crispr Therapeutics and Caribou Biosciences

Given the investment horizon of 90 days Crispr Therapeutics is expected to generate 1.3 times less return on investment than Caribou Biosciences. But when comparing it to its historical volatility, Crispr Therapeutics AG is 1.78 times less risky than Caribou Biosciences. It trades about 0.03 of its potential returns per unit of risk. Caribou Biosciences is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  221.00  in Caribou Biosciences on September 2, 2024 and sell it today you would lose (2.00) from holding Caribou Biosciences or give up 0.9% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Crispr Therapeutics AG  vs.  Caribou Biosciences

Crispr Therapeutics

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Crispr Therapeutics AG are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating basic indicators, Crispr Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

Caribou Biosciences

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Caribou Biosciences are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak fundamental drivers, Caribou Biosciences unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Crispr Therapeutics and Caribou Biosciences

The main advantage of trading using opposite Crispr Therapeutics and Caribou Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Crispr Therapeutics position performs unexpectedly, Caribou Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Caribou Biosciences will offset losses from the drop in Caribou Biosciences' long position.

The idea behind Crispr Therapeutics AG and Caribou Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.